Blog
RSS FeedPosted by Michael Wonder on 31 Aug 2025
FDA approval of Leqembi subcutaneous formulation charts path to combination therapies for Alzheimer's disease
29 August 2025 - Subcutaneous delivery increases accessibility and introduces potential for at home administration, following model of diabetes and ...
Posted by Michael Wonder on 24 Feb 2022
FDA approves treatment for wider range of patients with heart failure
24 February 2022 - Today, the U.S. FDA approved Jardiance (empagliflozin) to reduce the risk of cardiovascular death and hospitalization ...
Posted by Michael Wonder on 24 Feb 2022
EMA recommends approval of Spikevax for children aged 6 to 11
24 February 2022 - EMA’s CHMP has recommended granting an extension of indication for the COVID-19 vaccine Spikevax to include use ...
Posted by Michael Wonder on 24 Feb 2022
COVID-19 vaccine weekly safety report (24 February 2022)
24 February 2022 - To 20 February 2022, the TGA has received 451 reports which have been assessed as likely to ...
Posted by Michael Wonder on 24 Feb 2022
Government of Canada signs new COVID-19 antibody therapy agreement
23 February 2022 - The Government of Canada is committed to protecting the health and safety of everyone in Canada ...
Posted by Michael Wonder on 24 Feb 2022
ATAGI recommendations on the use of Spikevax (Moderna) COVID-19 vaccine in children aged 6 to 11 years
23 February 2022 - The Australian Technical Advisory Group on Immunisation (ATAGI) has made recommendations for the use of the Moderna ...
Posted by Michael Wonder on 23 Feb 2022
FDA approves nalmefene hydrochloride 2 mg/2 mL injection for the treatment of known or suspected opioid overdose with natural or synthetic opioids
23 February 2022 - Purdue Pharma announced today that FDA has approved its abbreviated new drug application for nalmefene hydrochloride 2 ...
Posted by Michael Wonder on 23 Feb 2022
FDA permits marketing of first condom specifically indicated for anal intercourse
23 February 2022 - Other FDA cleared condoms can continue to be used for contraception and to prevent sexually transmitted infections. ...
Posted by Michael Wonder on 23 Feb 2022
Theragnostics announces US FDA approval for its radiodiagnostic imaging drug NephroScan (kit for the preparation of Technetium Tc 99m succimer injection)
23 February 2022 - NephroScan is now U.S. FDA approved for the preparation of Tc-99m DMSA. ...
Posted by Michael Wonder on 23 Feb 2022
TGA checks need for another vax booster
23 February 2022 - Australia is looking at whether to offer a fourth COVID dose ahead of the flu season ...
Posted by Michael Wonder on 23 Feb 2022
Annual report 2021: more Government assignments and increased EU cooperation on TLV
23 February 2022 - In 2021, the Swedish Dental and Pharmaceutical Benefits Agency, TLV, reported a number of urgent government assignments ...
Posted by Michael Wonder on 23 Feb 2022
Medtronic receives FDA approval for InterStim X system, the next generation of the most personalised sacral nerve stimulation therapy for bladder and bowel control
22 December 2022 - New InterStim X system provides 10 to 15 years of battery life without the need to recharge. ...
Posted by Michael Wonder on 23 Feb 2022
‘Grumpy’ TGA boss unloads over people downplaying COVID’s effect on kids
23 February 2022 - The head of Australia’s medicines regulator has unloaded on those downplaying the effect COVID-19 has on ...
Posted by Michael Wonder on 23 Feb 2022
PHARMAC recommends funding cystic fibrosis medicine Trikafta but needs more funding
23 February 2022 - PHARMAC’s clinical experts are recommending cystic fibrosis drug Trikafta be funded for those aged over 12 ...
Posted by Michael Wonder on 23 Feb 2022
MSAC Secretariat publishes agenda for June 2022 ESC meeting
23 February 2022 - The MSAC Secretariat has published a list of applications scheduled to be considered by the ESC ...
Posted by Michael Wonder on 23 Feb 2022
PHARMAC’s clinical experts recommend funding Trikafta
23 February 2022 - PHARMAC today announces its clinical advisory committee PTAC has recommended funding cystic fibrosis treatment Trikafta with ...